[Federal Register Volume 64, Number 219 (Monday, November 15, 1999)]
[Notices]
[Pages 61892-61893]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-29670]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Care Financing Administration
[HCFA-3027-N]
Medicare Program; Meeting of the Executive Committee of the
Medicare Coverage Advisory Committee--December 8, 1999
AGENCY: Health Care Financing Administration (HCFA), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting of the Executive
Committee of the Medicare Coverage Advisory Committee (MCAC). The
Committee provides advice and recommendations to the agency about
clinical coverage issues. The Committee will hear reports from recent
meetings of MCAC medical specialty panels. The Committee will also
consider how to provide guidance to, and substantive coordination
among, MCAC panels. For example, the Committee will consider the levels
of evidence, types of information needed, and the nature of issues that
will be considered by the medical specialty panels at future public
meetings. Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. App. 2, section 10 (a)(1) and (a)(2)).
DATES:
The Meeting: December 8, 1999, from 8 a.m. until 4 p.m., E.D.T.
Deadline for Presentations and Comments: Submit formal
presentations and written comments to the For Further Information
Contact by November 18, 1999, 5 p.m., E.S.T.
Special Accomodations: Persons attending the meeting who are
hearing or visually impaired and have special requirements, or a
condition that requires special assistance or accommodations, must
notify the Executive Secretary by November 18, 1999, 5 p.m., E.D.T.
ADDRESSES:
The Meeting: The meeting will be held at the Health Care Financing
Administration, Main Auditorium, 7500 Security Boulevard, Baltimore,
Maryland 21244.
Presentations and Comments: Submit formal presentations and written
comments to Sharon K. Lappalainen, Executive Secretary; Office of
Clinical Standards and Quality; Health Care Financing Administration;
7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
Website: You may access up-to-date information on this meeting at
www.hcfa.gov/quality/8b.htm.
SUPPLEMENTARY INFORMATION:
On August 13, 1999, we published a notice (64 FR 44231) to
establish the Medicare Coverage Advisory Committee (MCAC) to provide
advice and recommendations to us about clinical coverage issues. This
notice announces the following public meeting of the MCAC:
Current Members of the Committee
Thomas V. Holohan, M.A., M.D., (FACP); Leslie P. Francis, JD,
Ph.D.; John H. Ferguson, M.D.; Robert L. Murray, Ph.D.; Alan M. Garber,
M.D., Ph.D.; Michael D. Maves, M.D., M.B.A.; David M. Eddy, M.D.,
Ph.D.; Frank J. Papatheofanis, M.D., Ph.D.; Harold C. Sox, M.D.; Ronald
M. Davis, M.D.; Daisy Alford-Smith, Ph.D.; Joe W. Johnson, D.C.; Robert
H. Brook, M.D., Sc.D.; Linda A. Bergthold, Ph.D.; and Randel E.
Richner, M.P.H.
Meeting Topic
The Committee will hear reports from recent meetings of MCAC
medical specialty panels. The Committee will also consider how to
provide guidance to, and substantive coordination among, MCAC panels.
For example, the Committee will consider the levels of evidence, types
of information needed, and the nature of issues that will be considered
by the medical specialty panels at future public meetings.
Procedure and Agenda
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 90 minutes on the day
of the meeting. The Committee may limit the number and duration of oral
presentations to the time available. If you wish to make formal
presentations, you must notify the For Further Information Contact, and
submit the following by the Deadline for Presentations and Comments
date listed in the Dates section of this notice: a brief statement of
the general nature of the information you wish to present, the
[[Page 61893]]
names and addresses of proposed participants, and an estimate of the
time required to make the presentation. We will request that you
declare at the meeting whether or not you have any financial
involvement with manufacturers of any items or services being discussed
(or with their competitors).
After public presentation, we will make a presentation to the
Committee. After our presentation, the Committee will deliberate openly
on the topic. Interested persons may observe the deliberations, but the
Committee will not hear further comments during this time except at the
request of the chairperson. At the end of the Committee deliberations,
the Committee will allow a 30-minute open public session for any
attendee to address issues specific to the topic. After which, the
members will vote and the Committee will make its recommendation.
Authority: 5 U.S.C. App. 2, section 10 (a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: November 5, 1999.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care
Financing Administration.
[FR Doc. 99-29670 Filed 11-12-99; 8:45 am]
BILLING CODE 4120-01-P